This week, 13-19 November, we support Cervical Cancer Awareness Week and look at how Australia has taken a pioneering step in the global fight against cervical cancer.
Since July 1st, 2022, Australia has been providing women with self-collection kits for cervical screening, irrespective of their age or prior screening history. This significant step highlights the country’s commitment to eradicating cervical cancer.
NATA plays a vital role in this global leading approach. The introduction of self-collection kits for cervical screening demonstrates the efficacy and reliability of accredited laboratory testing, endorsed by NATA. This proactive measure aims to enhance the accessibility and convenience of screening, ensuring more women have access to early detection and treatment.
In an enlightening interview conducted last year, Marion Saville, Executive Director of the Australian Centre for the Prevention of Cervical Cancer, and Karen Canfell, Director at The Daffodil Centre, emphasised the critical role of accredited testing in the ambitious goal of eliminating cervical cancer by 2028. Their insights shed light on the contributions of NATA-accredited testing in improving the efficiency and accuracy of screening procedures.
Join NATA and Australia in the journey towards a future free from cervical cancer. Together, we can set the stage for a world where cervical cancer becomes a thing of the past.
